A

AUM Biosciences

17 employees

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Precision medicine
Asian-biotech
drug development
cancer
Digitalhealth
oncology
small molecules
biotech

Date founded

2018

Funding rounds raised

Total raised

$27M

from 3 investors over 3 rounds

A

AUM Biosciences raised $27M on October 12, 2021

Investors: Everlife Asia, SPRIM Global and A*STAR - Agency for Science, Technology and Research

FAQ